跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 54,104 条关于
“advanced endometrial carcinoma”
全部
54,104
临床试验
40,011
药物
198
机构
157
资讯
13,738
去年
NRG258 Trial: Chemoradiation Fails to Improve Overall Survival in Advanced Endometrial Cancer
11个月前
KEYTRUDA Plus LENVIMA Shows Durable 5-Year Survival Benefit in Advanced Endometrial Cancer
2年前
Pembrolizumab Plus Lenvatinib Fails to Meet Survival Endpoints in Advanced Endometrial Cancer
11个月前
Eisai Presents 5-Year Survival Data for Lenvatinib Plus Pembrolizumab in Endometrial Cancer at ESMO 2025
去年
Eisai to Present Long-Term LEAP-002 Data and Novel Pipeline Advances at ASCO 2025
去年
Advances in Immunotherapy and Precision Medicine Transform Endometrial Cancer Treatment
去年
First-Line Lenvima Plus Keytruda Misses Mark in Endometrial Cancer
3年前
Pembrolizumab and Lenvatinib Combination Fails to Improve Overall Survival in Melanoma and Colorectal Cancer
2年前
Dostarlimab Shows Superior Survival Outcomes Across Multiple Endometrial Cancer Molecular Subgroups in Phase 3 RUBY Trial
去年
European Commission Approves Pembrolizumab Regimens for Endometrial and Cervical Cancers
第 1 页，共 1374 页
上一页
下一页
